Preprint / Version 1

The Price of Greed: Exploring the High Costs in US Healthcare


  • Andrew Chen Polygence



Healthcare, Cost, private healthcare


This paper covers the topic of why healthcare in the United States is more expensive than that of other demographically comparable countries. This paper’s main focus is on the competitive prices from private healthcare industries. The decreased funding from the US government increases the usage of private healthcare which escalates expenditures. By analyzing the patterns of the healthcare market, and examining the effects of profit-driven goals reveals the complexities of the cost of healthcare in the US. This research is to deepen our understanding of the challenges in the healthcare industry.


Centers for Medicare & Medicaid Services, Office of the Actuary, National Health Statistics Group; U.S. Department of Commerce, Bureau of Economic Analysis; and U.S. Bureau of the Census.

Roosa Tikkanen and Melinda K. Abrams, U.S. Health Care from a Global Perspective, 2019: Higher Spending, Worse Outcomes? (Commonwealth Fund, Jan. 2020).

Munira Z. Gunja, Evan D. Gumas, and Reginald D. Williams II, U.S. Health Care from a Global Perspective, 2022: Accelerating Spending, Worsening Outcomes (Commonwealth Fund, Jan. 2023).

Organisation for Economic Co-operation and Development, OECD Health Statistics 2019:

Definitions, Sources, and Methods (OECD Health, 2019).

Centers for Medicare & Medicaid Services. (2023). National Health Expenditure 2022,

NHE Fact Sheet | CMS [Fact sheet].

Additional Files